The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Bridge Project Events

The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care. Visit the Bridge Project page to learn more.

To encourage the formation of cross-disciplinary teams, we regularly hold informational sessions, workshops, and symposia based on complex translational problems in cancer. Check below for information about upcoming Bridge Project opportunities and events, or click the listings to the left to view videos from previous events.

Current opportunities

2016 Special Off-cycle Request for Applications: Pediatric Brain Tumors (with a preference for pediatric glioma)

Download the 2016 pediatric brain tumor RFA here.

Letter of Intent deadline: August 8, 2016

Please send an email to that includes the names and affiliations of your Bridge Project proposal team members, a title and a brief description of your proposal.

Proposal submission deadline: September 2, 2016 at 5 p.m.

2016 RFA details will be shared at the July 12 workshop (see below).

The review committee meeting, at which finalists present as a team, will take place on September 21, 2016. All team members must be available that day for an in-person interview. If your team members cannot make this date, or have time restrictions, please let us know when you submit your letter of intent. 


2016 Bridge Project Workshop: July 12, 2016

We strongly encourage anyone interested in applying for this opportunity to attend the July 12 Workshop at the Koch Institute (clinicians as well as researchers, including faculty and trainees). Tyler Jacks and David Livingston will provide brief updates and share tips for this special RFA which will likely strengthen your application. There will also be presentations by clinicians and researchers actively working in the area of pediatric brain tumor research and/or clinical care. Immediately following the workshop, there will be a networking reception. The intention is to spur the formation of new research ideas and collaborations between the two institutions (KI/MIT and DF/HCC).


11:00 am David Livingston, M.D. (Deputy Director, DF/HCC) / Tyler Jacks, Ph.D. (Director, Koch Institute) - Welcome and introductory remarks

11:10 am Torunn Yock, M.D. (Massachusetts General Hospital) / David Ebb, M.D. (Massachusetts General Hospital) - "Clinical overview of pediatric brain tumors"

11:35 pm Keith Ligon, M.D., Ph.D. (Dana-Farber Cancer Institute) - "Pathology, precision medicine and models  of pediatric gliomas"  

12:00 pm Rameen Beroukhim, M.D., Ph.D. (Dana-Farber Cancer Institute) - “Genomic studies of pediatric low-grade gliomas”

12:25 pm Short break, lunch provided

12:50 pm Charles Stiles, Ph.D. (Dana-Farber Cancer Institute) - "Targeted Therapies for Pediatric Low-Grade Astrocytomas"

1:15 pm Karen Wright, M.D. (Dana-Farber Cancer Institute) - "Current clinical trials and challenges"

1:40 pm Scott Manalis, Ph.D. (Koch Institute) - "Measuring single cell growth – biological insights and clinical opportunities"

2:05 pm Fred Lam, M.D., Ph.D. (Koch Institute) -  "Delivery of novel combination therapies to gliomas using a targeted liposomal nanoparticle system” 

2:30 - 3:30 pm - Networking Hour


Register for the event here:


Regular 2016 Bridge Project RFA coming soon.